Assobiomedica's healthcare efficiency views prove timely, as Italy embraces austerity
This article was originally published in Clinica
The Italian medtech industry has advocated increasing the cost-efficiency of the health system. The suggestions are well timed; this week the Italian government announced austerity measures worth €24bn over 2011-12, or about 1.6% of GDP.
You may also be interested in...
EU Regulatory Round-Up, February 2020: Brexit And Swixit Threaten Huge Disruption Amidst MDR Uncertainty
Complying with the EU’s new Medical Device Regulation would be hard enough. But more layers of uncertainty – especially Brexit and Swixit ̶ mean European medtech is navigating very turbulent waters right now.
Fresenius Kabi has reported sales ahead by 6% in 2019, as growth in emerging markets helped to offset a subdued increase in North America. Meanwhile, the firm has pushed back financial expectations for its biosimilars by a year.
Fresenius Kabi and Vifor Pharma have agreed to create a joint venture in China for intravenous iron products.